Amgen is seeking FDA approval for etelcalcetide, the first calcimimetic agent administered intravenously after dialysis to treat secondary hyperparathyroidism in patients with chronic kidney disease.
Pharmacists must prepare for full enforcement of the Drug Supply Chain Security Act (DSCSA) in order to avoid significant penalties associated with noncompliance.
This weekly video program highlights the latest in pharmacy news, product news, and more.
The FDA today approved evolocumab (Repatha) injection, a new treatment for patients unable to get their low-density lipoprotein (LDL) cholesterol under control with current treatment options.
Angela Patterson, MSN, chief nurse practitioner officer of the CVS MinuteClinic, talks about the roadblocks that pharmacists face in treating acne, and talks about how to overcome these problems.
Drug manufacturers spent $3.4 billion on advertising the top 10 brand-name prescription drugs last year.
Pharmacies are now stocking Mylan’s generic version of Pfizer’s Zosyn injection.
Jessica Kerr, PharmD, CDE, assistant department chair at Southern Illinois University Edwardsville, discusses what pharmacists should know about Afrezza.
A new type 2 diabetes (T2D) treatment for adult patients, empagliflozin and metformin (Synjardy), was approved by the FDA today.
Kristene Diggins, FAANP, CNE, NEA-BC, DNP, DCC, MBA, manager of professional practice at MinuteClinic, talks about trends in diabetes management that pharmacists can participate in.
An estimated 6 to 12 million individuals in the United States develop head lice each year, with most cases occurring in children ages 3 to 11.
If you are receiving radiation and chemotherapy for cancers of the head and neck, you may experience oral mucositis.
Peptic ulcer disease leads to 1 million hospitalizations and 6500 deaths annually.
Dietary supplements are intended to supplement the diet, not to cure, prevent, or treat diseases or replace the variety of foods important to a healthy diet.
Early detection and treatment are key to protecting eyesight.
Strategic Alliance Partners